Cytotoxins and Immunotoxins for Cancer Therapy: Clinical Applications

Hardcover (Print)
Buy New
Buy New from
Used and New from Other Sellers
Used and New from Other Sellers
from $163.37
Usually ships in 1-2 business days
(Save 18%)
Other sellers (Hardcover)
  • All (6) from $163.37   
  • New (4) from $163.37   
  • Used (2) from $231.44   


Recent advances in cytotoxins and immunotoxins are accelerating our understanding of cancer and leading to more effective therapeutic treatments. Although a large number of articles have been published on these cytotoxins and immunotoxins, this important information has yet to be compiled into one comprehensive resource.

For the first time, Cytotoxins and Immunotoxins for Cancer Therapy: Clinical Applications presents state-of-the-art information on various cytotoxins and immunotoxins in a single, highly anticipated publication. The editors bring together leading researchers to summarize their work and discuss clinical trial data concerning some of the most widely studied tumors. The book describes Pseudomonas exotoxin (PE)-based immunotoxins and presents the latest results from clinical trials for the treatment of recurrent glioblastoma and other human cancers. It reviews the role of ricin-based immunotoxins for the treatment of lymphoma, explores several DT-based immunotoxins, and details the preclinical and clinical development of the first FDA-approved cytotoxin.

With a focus on clinical developmental approaches to the use of cytotoxins and immunotoxins, this book discusses exciting possibilities for cancer therapy. It is a valuable resource for scientists, researchers, and clinicians involved in the development of new treatments that can help keep cancer under control, and may ultimately lead to a cure.

Read More Show Less

Product Details

  • ISBN-13: 9780415263658
  • Publisher: CRC Press
  • Publication date: 10/27/2004
  • Series: Pharmaceutical Science Series
  • Pages: 240
  • Product dimensions: 6.40 (w) x 9.60 (h) x 0.72 (d)

Table of Contents

Preface: An Overview of Immunotoxins and Cytotoxins in Clinical Trials
Targeting of Pseudomonas Exotoxin-based Immunotoxins to Hematologic Malignancies, Robert J. Kreitman
Interleukin-4-targeted Cytotoxin for Recurrent Glioblastoma Therapy, Koji Kawakami, Mariko Kawakami, Robert J. Kreitman, and Raj K. Puri
Interleukin-13 Receptors and Development of IL-13-Pseudomonas Exotoxin for Human Cancer Therapy, Bharat H. Joshi, Syed R. Husain, Pamela Leland, and Raj K. Puri

Ricin Immunotoxins in Lymphomas, Ronald Schnell and Andreas Engert

Diphtheria-based Immunotoxins: Targeting Overexpressed Interleukin-13 Receptor and Urokinase-type Plasminogen Activator Receptor on Glioblastoma Multiforme, Edward Rustamzadeh, Walter A. Hall, Deborah Todhunter, and Daniel Vallera
DAB389IL-2 (Ontak): Development and Therapeutic Applications, Paul J. Shaughnessy, and Charles F. LeMaistre
Transferrin Diphtheria Toxin for Brain Tumor Therapy, Simon Long and Patrick Rossi
GM-CSF Receptor Targeted Therapy of Human Leukemia, Arthur E. Frankel, Philip D. Hall, Dongsun Cao, Tie Fu Liu, Marlena Moors, Kimberley A. Cohen, Andrew M. Thorburn, and Robert J. Kreitman
VEGF-diphtheria toxin for Targeting of Tumor Blood Vessels, Indira V. Subramanian, and Sundaram Ramakrishnan

cBR-96-doxorubicin (SGN-15) for Metastatic Breast Cancer Therapy, Lisle Nabell, Clay B. Siegall, and Mansoor N. Saleh
Anti-CD33 Calicheamicin Immunoconjugate Therapy of Acute Myeloid Leukemia, Charalambos Andreadis, Selina M. Luger Selina, and Edward A. Stadtmauer

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star


4 Star


3 Star


2 Star


1 Star


Your Rating:

Your Name: Create a Pen Name or

Barnes & Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation


  • - By submitting a review, you grant to Barnes & and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Terms of Use.
  • - Barnes & reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)